If you wish to be added to this list, please contact Isabelle Charles at i.m.charles@berkeley.edu with information about your lab.
| Investigator | Affiliation | Interests | Keywords |
|---|---|---|---|
| Peter A. Barry | UC Davis | Mechanisms of cytomegalovirus (CMV) persistence and pathogenesis; Nonhuman primate models of human CMV; Modeling of human CMV vaccine strategies in a nonhuman primate model | |
| Paul A. Luciw | UC Davis | Viral Pathogenesis and Therapy (HIV and AIDS) Biomarkers for Infectious Diseases and Cancer | Retroviruses, Persistent Infection, Nonhuman Primate Models, HIV and AIDS |
| Raul Andino | UCSF | RNA virus replication, virus population dynamics and evolution | RNA virus, virus detection by host, RNAi, antiviral response. |
| Jody Baron | UCSF | Innate and adaptive immunity to viral pathogens. | Immune response, Hepatitis B |
| Nichole Baumgarth | UC Davis | We are interested in understanding the regulation of immunity to influenza virus with particular emphasis on the regulation of the local B cell responses by innate signals and the B cell subsets that are contributing to immune defense against respirato | Immune regulation; antiviral immunity; humoral immunity; respiratory tract immunity; B cell subset responses; B-1 cells; natural antibodies |
| Monica Borucki | Lawrence Livermore National Lab | evolution, quasispecies, forensics | evolution, quasispecies, forensics |
| Gertrude Buehring | UC Berkeley | My area of research is oncogenic viruses--viruses that cause human cancer. | molecular epidemiology, oncogenic viruses and human cancers |
| Jan Carette | Stanford | Research focuses on identification of host genes using haploid genetic screens in human cells; obtain fundamental insights on how viruses hijack cellular processes and on host defense mechanisms; facilitate the development of new therapeutic strategies. | virology, immunology, genetics, influenza |
| Charles Chiu | UCSF | Metagenomics-Based Technologies for Virus Detection and Discovery | Viral Detection and Discovery, Clinical Diagnostics, Pathogen Detection Microarrays, Deep Sequencing, Metagenomics |
| Jinah Choi | UC Merced | HCV, oxidative stress, mutation, interferon | |
| Candice Clay | California National Primate Research Center | Our lab has largely focused on understanding the development of asthma, exploring the relationship between childhood asthma and exposure to allergens and environmental air pollution. | Respiratory syncytial virus, Rhinovirus, influenza, Tobacco, side stream cigarette smoke, asthma |
| Lark Coffey | UC Davis | viral molecular evolution, viral genetic factors that promote mosquito-borne virus emergence and disease | mosquito-borne viruses, virus mutations, Zika virus, chikungunya virus |
| Laurent Coscoy | UC Berkeley | herpesvirus, innate immune response | |
| Charles Craik | UCSF | The Craik lab focuses on viral proteases with a current emphasis on HIV and the human herpesviruses. Specifically, we are interested in host-virus interactions involving proteases as well as small molecules and biologics for the modulation of protease act | small-molecule allosteric inhibition, protein-protein interaction, host-virus interaction, restriction factor identification, structure-function characterization, proteases |
| Joseph DeRisi | UCSF | Genomics, proteomics, informatics, etc. | Viral discovery, RNA viruses, metagenomics, viral-host interactions, viral recombination |
| Jerome Deval | Alios BioPharma | Alios is a biotechnology company located in South San Francisco, California, that is developing novel medicines to treat viral diseases. Alios has two platform technologies: novel nucleoside/nucleotide chemistries and small molecule activators of the RN | Antivirals, RNA polymerases, drug discovery, HCV, Influenza virus, RSV, nucleoside, RNase L |
| Rebecca DuBois | UC Santa Cruz | The DuBois Lab seeks to understand the molecular mechanisms of virus infections, and to use this information to develop new vaccines and antiviral therapeutics. | Structural virology, vaccine design, antiviral antibody therapies |
| James E.K. Hildreth | UC Davis | My laboratory research is focused on understanding mechanisms by which HIV subverts host pathways and molecules during its replication cycle. We are particularly interested in the role of cholesterol and cholesterol homeostatic pathways in virus entry, vi | HIV-1, cholesterol, HIV-1 and co-infecting viruses |
| Shirit Einav | Stanford | Focuses on better understanding interactions of Flaviviridae with the human host and their inhibition. | Flaviviridae, viral-host protein-protein interactions, antivirals, assembly, budding |
| Bryce Falk | UC Davis | Work with plant viruses; their biology and molecular biology, and engineering plants for resistance against virus infections. | |
| Margaret Feeney | UCSF | Immunopathogenesis of HIV and malaria in childhood | Immunopathogenesis, HIV, malaria, T-cell response, immune response |
| Ellen Fiss | Roche Molecular Systems | Diagnostic assays for the detection of viruses. | diagnostic, assay, detection |
| Alan Frankel | UCSF | Assembly and evolution of RNA-protein complexes and virus-host interactions. HIV – Tat and Rev proteins: their biochemistry, structure and interactions. | RNA-protein, HIV, Tat protein, Rev protein, virus-host interaction |
| Scott Geller | Bay Genomics | With a background in molecular neuroscience, animal models of disease, and especially dangerous pathogen handling and detection, Bay Genomics is a private lab and scientific resource for the greater San Francisco Bay Area, committed to helping local sci | cell culture, molecular biology, immunology, microscopy, and genomics studies |
| Britt Glaunsinger | UC Berkeley | Studying how viruses interface with host gene expression machinery; emphasis on gammaherpesviruses. | herpesvirus, RNA turnover, host shutoff |
| Harry Greenberg | Stanford | Long-standing interests in rotavirus, influenza, hepatitis B and C and Noroviruses. Interests in viral immunity (innate and acquired), pathogenesis and vaccines | Rotavirus, influenza, hepatitis B and C, notaviruses, viral immunity, pathogensis, vaccines |
| John Gross | UCSF | The control of eukaryotic gene expression at the level of mRNA metabolism. Biology of HIV-host complexes. | gene expression, mRNA metabolism, HIV-host |
| Eva Harris | UC Berkeley | Correlate of protection of vaccines, cross-reactive B cell response | |
| Laura Hertel | CHORI, Center for Immunobiology and Vaccine Development | Mechanisms regulating human cytomegalovirus (CMV) tropism and latency, in particular, how CMV gains access to specific cells of the innate immune system, the dendritic cells, and how the CMV genome is maintained within the host bone marrow cells for life. | Human Cytomegalovirus, CMV, tropism, latency, vaccine, innate immune system |
| Christopher J. Miller | UC Davis | My laboratory utilizes non-human primate models of AIDS and influenza A virus infection to define the pathogenesis of these viral infections, study the nature of protective antiviral immunity, and test vaccines and immunotherapeutic strategies to preven | Viral Pathogenesis Anti-viral Immunity Mucosal Immunology RNA viruses |
| Hong Jin | MedImmune | Negative strand RNA viruses | |
| Nevan Krogan | UCSF | High-troughput analysis of host-pathogen interactions in HIV, enteroviruses, dengue virus | host-pathogen interaction, HIV, enterovirus, dengue virus |
| Desiree LaBeaud | Stanford | Explore the risk factors of arthropod-borne viral diseases (Rift Valley fever (RVFV), dengue (DENV) and chikungunya (CHIKV) viruses) to understand transmission, optimize prevention and control, and estimate the proportion of acute febrile illness. | anthropod-borne viral diseases, Rift Valley fever, RVFV, dengue, DENV, chikungunya, CHIKV, transmission, epidemiology, diagnostics |
| Jennifer Lavail | UCSF | Axonal Transport Mechanisms of Herpes Simplex Virus in CNS Neurons | axonal transport, herpes simplex virus, CNS neurons |
| Jay Levy | UCSF | Research in our laboratory deals with virologic, immunologic and molecular studies of HIV pathogenesis and vaccine development. Specific attention is given to the innate immune response against HIV including that of dendritic cells and CD8+ lymph | Innate immunity, HIV, non-cytotoxic CD8+ cell antiviral activity, HIV vaccine development |
| Zengji Li | BN ImmunoTherapeutics | Poxvirus vector cancer vaccine | |
| Patricia LiWang | UC Merced | The LiWang Lab research interests include structural biology of chemokines, applications to HIV and inflammatory diseases. | HIV inhibition and inflammation. |
| Uri Lopatin | Assembly Pharmaceuticals | HBV, drug development, immunology, allostery | |
| Susan Lynch | UCSF | Human microbiome,including its perturbations in HIV patients. Chronic inflammatory disease. | human microbiome, HIV, chornic inflammatory disease |
| Stephanie Mandl | BN ImmunoTherapeutics | BN ImmunoTherapeutics is a biotech company that is developing poxvirus based immunotherapies for cancer. | Tumor immunology, breaking tolerance, vaccine development, immunotherapy |
| B. Matija Peterlin | UCSF | Study the molecular biology of HIV and endogenous retroviruses with special emphasis on transcription, restriction and proviral latency; focus is on Tat:P-TEFb, Nef, Vif:APOBEC, and aspects of other accessory proteins. | Transcription, latency, reservoir, restriction, integration, silencing, replication |
| Mehrdad Matloubian | UCSF | Lymphocyte migration and autoimmune disease as revealed by the lymphocytic choreomeningitis virus | lymphocyte migration, autoimmune disease, lymphocytic choreomeningitis virus |
| Alison McCormick | Touro University, California | Vaccines, Virology, Public Health | |
| Mike McCune | UCSF | Pathogenic Mechanisms, Treatment, and Prevention of HIV Disease | pathogenic mechanisms, treatment, prevention, HIV |
| Mohammad Mofrad | UC Berkeley (Bioengineering) | Using computational models to shed light on the process by which HIV Rev oligomerizes on the Rev Response Element (RRE) sequence of the viral genome and recruits crm1 (chromosome region maintenance 1; also referred to as exportin1) to export this genome. | HIV, HIV replication, viral genome, bioengineering. |
| Brian Murphy | UC Davis | Interested in retroviral promoter function/regulation and how it relates to viral pathogenesis (FIV, SIV, CAEV, ENTV, JSRV). | transcriptional regulation and latency- host:viral cross-regulation |
| Doug Nixon | UCSF | Cellular immune responses to HIV | cellular immune responses, HIV, immunity |
| Philip Norris | Blood Systems Research Institute | Understanding the role CD4+T helper cells play in the body's immune defense against viral infections, such as HIV. Understanding acute immune response to West Nile virus and other flavivirus infection. Defining the types and mechanisms of immune reactio | T-cell immunology, cytokine networks, human viral pathogenesis |
| Patricia Pesavento | School of Veterinary Medicine, UC Davis | We divide our research time between enigmatic cases of disease in group-housed (shelter) animals, and a basic research program on host:viral pathogen interactions. What unites all of our work is our desire to study natural disease and to help make sense, | virus, pathology, oncogenesis |
| Daniel Portnoy | UC Berkeley | Pathogen immune evasion, pathogenesis | Immune evasion, pathogenesis |
| Mary Premenko-Lanier | SRI | Cellular immune dysfunction during persistent viral infections | cellular immune dysfunction, viral infection, immunity |
| David Raulet | UC Berkeley | We are interested in how natural killer cells recognize virus-infected cells. A specific focus concerns how viral infections induce expression in infected cells of cell surface ligands recognized by NK cell activating receptors, such as NKG2D. | Immune activation, innate immunity |
| Peter Sarnow | Stanford | Virus-host interactions, cellular and viral translation, miRNA regulation of gene expression | |
| David Schaffer | UC Berkeley | Stem Cells, Gene therapy and HIV | gene therapy, RNA viruses, HIV-1, viral latency |
| Barbara Shacklett | UC Davis | Mucosal immunity to HIV and SIV (gastrointestinal and reproductive mucosa). Trafficking of antigen-specific T-cells to mucosal tissues and the central nervous system. Natural Killer cells and non-classical effector cells in mucosal tissues. | Mucosal immunity Cytotoxic T-cells Host Responses Adaptive immunity |
| Mina Sun | UC Berkeley | Virus DNA packaging mechanisms | virus, DNA, virology |
| Jane Sykes | UC Davis | Viral infections of dogs and cats | Clinical virology |
| Julian Symons | Alios BioPharma Inc. | Alios BioPharma is a biotechnology company located in South San Francisco, California, that is developing novel medicines aimed at the treatment of viral diseases. Alios is developing direct acting antiviral agents against several human viral pathogens of | Chronic hepatitis C, hepatotropic viruses, respiratory viruses, RNase L, direct acting antiviral agents. |
| Cristina Tato | CZ Biohub | Global health and infectious diseases | |
| Russell Vance | UC Berkeley | Innate immunity, host-pathogen biology, inflammasome activation | |
| Jonatahn Weissman | UCSF | Global monitoring of protein translation and mRNA transcription, including in viral systems | protein translation, mRNA transcription, viral systems |
| JoAnn Yee | UC Davis | Infectious Disease in Animal Models | Infectious Disease in Nonhuman primates. |